BCPP Georgia

Borshchahivskiy Chemical-Pharmaceutical Plant (BCPP) is a leading Ukrainian pharmaceutical company that develops, manufactures, and markets a broad portfolio of generic and original medicinal products. Established in 1947 and headquartered in Kyiv, the company produces over 100 pharmaceutical products across diverse therapeutic areas, including cardiology, neurology, gastroenterology, and infectious diseases. BCPP was the first Ukrainian manufacturer to receive EU GMP certification and maintains a significant international footprint, exporting to countries such as Georgia, Vietnam, and several EU member states. The company operates a full-cycle production complex that includes the synthesis of active pharmaceutical ingredients (APIs) and the manufacturing of finished dosage forms such as tablets, capsules, and sterile injectables.